Alnix
Cetirizine dihydrochloride
Brand Name, Dosage Format and Strength
Alnix 5 mg/5 mL Syrup
Therapeutic Category
Immune System
Class
H1-receptor antagonist, Corticosteroid, Antihistamine,Nasal Corticosteroid, H1-receptor antagonist, Alpha adrenergic agonist, Ethanolamine
DOSAGE AND ADMINISTRATION
|
Age group
|
Oral Cetirizine Dose
|
|
|
2.5 mg/mL Syrup (Oral Drops)
|
5 mg/5 mL Syrup
|
|
|
Children 6 mos to less than 2 yrs
|
2.5 mg (1 mL) OD or BID
Maximum Dose: 5 mg/day
|
-
|
|
2 to 5 yrs
|
5 mg (2 mL) OD or 2.5 mg ( 1mL) BID
|
5 mL (1 tsp) OD or 2.5 mL (1/2 tsp) BID
|
|
6 to 11 yrs
|
-
|
10 mL (2 tsp) OD or 5 mL (1 tsp) BID
|
|
Adults and children 12 yrs and older
|
-
|
10 mL (2 tsp) OD
|
Or, as prescribed by a physician.
|
Dosage in Renal and Hepatic Impairment
|
Oral Solution (1mg/mL)
|
|
Adults and children ≥ 12 yrs of age:
· decreased renal function
(CLCR = 11-31 mL/min),
· on hemodialysis
(CLCR = < 7 mL/min),
· with hepatic impairment
|
5 mL (1 tsp)
OD
|
|
Note: Pediatric patients aged 6-11 yrs with renal and hepatic function should use the lowest recommended dose. Because of the lack of pharmacokinetic and safety information for cetirizine in children below the age of 6 yrs with impaired renal or hepatic function, use of cetirizine in these patients is not recommended.
|
|